Correlation Between Marker Therapeutics and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Marker Therapeutics and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marker Therapeutics and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Marker Therapeutics and Edgewise Therapeutics, you can compare the effects of market volatilities on Marker Therapeutics and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marker Therapeutics with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marker Therapeutics and Edgewise Therapeutics.
Diversification Opportunities for Marker Therapeutics and Edgewise Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Marker and Edgewise is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Marker Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marker Therapeutics are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Marker Therapeutics i.e., Marker Therapeutics and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Marker Therapeutics and Edgewise Therapeutics
Given the investment horizon of 90 days Marker Therapeutics is expected to generate 2.57 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, Marker Therapeutics is 1.06 times less risky than Edgewise Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 1,788 in Edgewise Therapeutics on September 2, 2024 and sell it today you would earn a total of 1,512 from holding Edgewise Therapeutics or generate 84.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Marker Therapeutics vs. Edgewise Therapeutics
Performance |
Timeline |
Marker Therapeutics |
Edgewise Therapeutics |
Marker Therapeutics and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Marker Therapeutics and Edgewise Therapeutics
The main advantage of trading using opposite Marker Therapeutics and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marker Therapeutics position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
Edgewise Therapeutics vs. Tff Pharmaceuticals | Edgewise Therapeutics vs. Eliem Therapeutics | Edgewise Therapeutics vs. Inhibrx | Edgewise Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |